Novavax Price to Book Ratio 2006-2021 | NVAX

Historical price to book ratio values for Novavax (NVAX) over the last 10 years. The current price to book ratio for Novavax as of October 22, 2021 is 13.37.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Novavax Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2021-10-22 134.56 13.40
2021-06-30 212.31 $10.04 21.14
2021-03-31 181.31 $14.03 12.92
2020-12-31 111.51 $8.84 12.61
2020-09-30 108.35 $1.69 64.06
2020-06-30 83.35 $3.01 27.65
2020-03-31 13.58 $-0.45 -30.51
2019-12-31 3.98 $-5.75 -0.69
2019-09-30 5.02 $-7.44 -0.68
2019-06-30 5.86 $-7.90 -0.74
2019-03-31 11.02 $-6.42 -1.72
2018-12-31 36.80 $-8.74 -4.21
2018-09-30 37.60 $-6.62 -5.68
2018-06-30 26.80 $-4.60 -5.83
2018-03-31 42.00 $-5.73 -7.33
2017-12-31 24.80 $-6.29 -3.94
2017-09-30 22.80 $-4.78 -4.77
2017-06-30 23.00 $-4.07 -5.65
2017-03-31 25.60 $-2.06 -12.43
2016-12-31 25.20 $-0.41 -61.63
2016-09-30 41.60 $3.67 11.33
2016-06-30 145.40 $8.13 17.88
2016-03-31 103.20 $13.70 7.53
2015-12-31 167.80 $21.68 7.74
2015-09-30 141.60 $27.20 5.21
2015-06-30 222.80 $28.86 7.72
2015-03-31 165.40 $29.84 5.54
2014-12-31 118.60 $19.23 6.17
2014-09-30 83.40 $21.95 3.80
2014-06-30 92.40 $23.66 3.90
2014-03-31 90.60 $18.26 4.96
2013-12-31 102.40 $19.48 5.26
2013-09-30 63.00 $20.77 3.03
2013-06-30 41.00 $9.07 4.52
2013-03-31 45.60 $10.26 4.45
2012-12-31 37.80 $10.85 3.48
2012-09-30 43.20 $9.06 4.77
2012-06-30 31.20 $9.24 3.38
2012-03-31 25.20 $8.90 2.83
2011-12-31 25.20 $9.20 2.74
2011-09-30 32.00 $9.50 3.37
2011-06-30 40.40 $9.81 4.12
2011-03-31 51.80 $9.60 5.40
2010-12-31 48.60 $10.64 4.57
2010-09-30 43.80 $12.11 3.62
2010-06-30 43.40 $11.30 3.84
2010-03-31 46.20 $12.59 3.67
2009-12-31 53.20 $13.95 3.81
2009-09-30 79.20 $14.35 5.52
2009-06-30 65.60 $13.45 4.88
2009-03-31 20.40 $10.98 1.86
2008-12-31 37.80 $13.23 2.86
2008-09-30 58.00 $16.33 3.55
2008-06-30 49.80 $15.23 3.27
2008-03-31 53.20 $18.01 2.95
2007-12-31 66.60 $20.36 3.27
2007-09-30 71.80 $23.19 3.10
2007-06-30 58.00 $25.89 2.24
2007-03-31 51.80 $28.14 1.84
2006-12-31 82.00 $30.43 2.70
2006-09-30 75.80 $32.24 2.35
2006-06-30 100.80 $33.75 2.99
2006-03-31 159.60 $35.53 4.49
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $10.023B $0.476B
NOVAVAX INC is a specialty biopharmaceutical company engaged in the research, development and commercialization of proprietary products focused on women's health and infectious diseases. Their technology platforms involve the use of proprietary, microscopic, organized, non-phospholipid structures as vehicles for the delivery of a wide variety of drugs and other therapeutic products, including certain hormones, anti-bacterial and anti-viral products and vaccine adjuvants.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76